Delivery Order SPE2DB20D2002-SPE2DB25FL73E
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Methylphenidate ER 27 mg tablets (100-count units) with a ceiling value of $1,190.65. This is a firm fixed-price delivery order with an ultimate completion date of September 15, 2025, and represents a competitively awarded, non-set-aside contract. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Methylphenidate Extended-Release 18 mg tablets in quantities of 100 units, with a ceiling value of $1,516.60. This firm fixed price delivery order, due for completion on September 12, 2025, represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Methylphenidate ER 54 mg tablets (100-count bottles) with a ceiling value of $1,386.06. This firm fixed-price delivery order, which is expected to be completed by July 30, 2025, represents a competitive procurement with no set-aside designation. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a $1,471.36 delivery order to AmerisourceBergen Drug Corp for Methylphenidate ER 18 mg tablets (100-count) on August 1, 2025, with an ultimate completion date of August 4, 2025. This firm fixed-price contract represents a non-set-aside, competitively awarded delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the vendor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Methylphenidate ER 27 mg tablets (100 count) valued at $4,175.73 on August 11, 2025, with completion targeted for August 12, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The products will be performed from AmerisourceBergen's Conshohocken, Pennsylvania location, where the company maintains its corporate headquarters as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Methylphenidate ER 54 mg tablets (100-count bottles) with a ceiling value of $1,285.98. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 11, 2025, with performance based in Conshohocken, Pennsylvania, where the vendor maintains its corporate headquarters. No set-aside designation was utilized for this procurement. This...
- The Defense Logistics Agency awarded a $1,212.28 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Methylphenidate Extended-Release 10mg capsules (100-count). This is a firm fixed price delivery order with no set-aside designation, exercised under a competitive procurement process. The products will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of July 22, 2025. This award represents a single...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Methylphenidate ER 54 mg tablets (100-count) with a ceiling value of $3,055.44. This firm fixed-price delivery order, which is expected to be completed by September 4, 2025, represents a competitively awarded contract with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Methylphenidate Extended-Release 36 mg tablets in quantities of 100 units. This contract, valued at $1,697.25, represents a firm fixed-price delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical prime vendor agreement running through December 2026. The delivery order was...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Methylphenidate ER 54 mg tablets (100-count bottles) under a firm fixed-price contract with a ceiling value of $1,431.52. This is a non-set-aside competitive award, with an ultimate completion date of June 3, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- SPE2DB20D2002Indefinite Delivery Contract
- SPE2DB20D2002-SPE2DB25FL73EDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of methylphenidate extended-release 54 mg tablets (100-count packages) at a ceiling value of $1,211.52. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 4, 2025. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The parent IDC enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. AmerisourceBergen, as a major pharmaceutical distributor and critical federal medical procurement vendor, has demonstrated capability to meet federal requirements through multiple competitively awarded contracts across diverse therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 9/3/25 |